Cases & Deals

BioMarin establishes global patent portfolio for novel human lysosomal protein technology

Clients BioMarin Pharmaceutical, Inc.

Jones Day advised BioMarin Pharmaceutical, Inc. in the establishment of its global patent portfolio and prosecuted key patents related to novel human lysosomal proteins.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.